Your search returned 2 results.

Results
	1.	Prolonged progression-free survival and preserved quality of life in the Canadian prospective study of tositumomab and iodine(131)-tositumomab for previously treated, rituximab-exposed, indolent non-Hodgkin lymphoma. [electronic resource] by Olney, Harold J Freeman, Marni A Stewart, Douglas A Mangel, Joy E White, Darrell J Elia-Pacitti, Julia O Producer: 20150818 In: Leukemia & lymphoma vol. 55 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Treatment of Hodgkin lymphoma with adriamycin, bleomycin, vinblastine and dacarbazine without routine granulocyte-colony stimulating factor support does not increase the risk of febrile neutropenia: a prospective cohort study. [electronic resource] by Minuk, Leonard A Monkman, Katherine Chin-Yee, Ian H Lazo-Langner, Alejandro Bhagirath, Vinai Chin-Yee, Benjamin H Mangel, Joy E Producer: 20120622 In: Leukemia & lymphoma vol. 53 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search